---
$id: https://graph.org.ai/products/commodity/51391715
$type: Product
source: UNSPSC
code: "51391715"
title: "Dipivefrin or dipivefrine"
class: "51391700"
classTitle: "Sympathomimetic or adrenergic amino alcohols"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dipivefrin or dipivefrine

**UNSPSC Code**: 51391715
**Class**: [Sympathomimetic or adrenergic amino alcohols](Sympathomimetic or adrenergic amino alcohols.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-glaucoma agent with the molecular formula C19H29NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8Q1PVL543G, chemically known as 4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat but generally known as dipivefrin, which bears US NIH Compound Identifier 3105. European Medicines Agency schedules Dipivefrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07217MIG. The term DIPIVEFRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules dipivefrin in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, DIPIVEFRIN remains the US FDA Preferred Term for this commodity. Dipivefrin bears US NLM identifiers UMLS ID C0058415 and NCI Concept Code C61729. SMILES: CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C.

